Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Toronto-Dominion Bank (TD) vs Twist Bioscience Corp (TWST) Price & Performance

Toronto-Dominion BankTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Toronto-Dominion Bank vs Twist Bioscience Corp — how do they compare? Toronto-Dominion Bank trades at $120.5 (market cap $197.03B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Toronto-Dominion Bank is far larger — about 36.2× Twist Bioscience Corp's market cap, and Toronto-Dominion Bank pays a 2.62% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.

TDTWST
Market Cap
$197.03B$5.45B
Sector
FinancialsHealth
52-Week High
$124.80$102.88
52-Week Low
$72.55$24.16
Dividend Yield
2.62%
Enterprise Value
$5.37B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Toronto-Dominion Bank

TD stock trades at $120.53, down 2.48% today, with a bearish technical signal despite recent earnings beats. The company reported strong Q1 2026 EPS of $1.74, beating expectations of $1.63, continuing a pattern of positive surprises. Revenue growth remains steady, climbing from $56.3B in 2024 to $61.3B in 2025. Analyst consensus is bullish with a $153 price target, though technical indicators show mixed signals with RSI neutral and ADX suggesting weakening trend strength.

TD presents a compelling value opportunity with a P/E of 20.08 and strong profitability metrics including 23.38% net income margin. However, investors face risks from volatile cash flow patterns and increasing debt-to-asset ratios. The stock's 27% upside to analyst targets and consistent dividend payments provide support, but macroeconomic sensitivity and regulatory scrutiny require careful monitoring.

Twist Bioscience Corp

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Toronto-Dominion Bank

Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.

Read more on TD

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST